GlassScriptPhysician profile
Robin M Levin
NPI 1659327211
$6,376.56
in general payments reported to CMS, 2019-2025
44 companies · $1,195 in 2025
The $1,195 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,493 · 2020: $395 · 2021: $439 · 2022: $726 · 2023: $1,061 · 2024: $1,069 · 2025: $1,195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,224 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,224.38 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,351.17 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $752.88 | 2019-2025 | |
| Revance Therapeutics, INC. | $469.27 | 2024-2025 | Daxxify |
| Sun Pharmaceutical Industries INC. | $379.89 | 2019-2025 | Ilumya, Winlevi |
| Lilly USA, LLC | $364.23 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $327.08 | 2019-2024 | Siliq, Jublia, Arazlo |
| Leo Pharma INC. | $310.01 | 2019-2025 | Adbry |
| E.R. Squibb & Sons, L.L.C. | $289.65 | 2022-2025 | Sotyktu |
| Pfizer INC. | $264.74 | 2019-2025 | |
| Botanix Sb INC | $152.80 | 2025 | Sofdra |
| Ucb, INC. | $137.59 | 2019-2025 | Bimzelx, Cimzia |
| Galderma Laboratories, L.P. | $137.12 | 2019-2025 | Nemluvio, Aklief, Oracea |
| Biofrontera INC. | $135.24 | 2019-2025 | Xepi, Bf-Rhodoled, Ameluz |
| Janssen Biotech, INC. | $130.23 | 2021-2025 | Tremfya, Simponi Aria, Simponi |
| Mayne Pharma Commercial LLC | $130.11 | 2019-2025 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.